When an unidentified patient who cannot communicate presents with symptoms and signs suggesting an acute stroke, the decision to thrombolyse is a particular challenge. In a time-pressured environment, clinicians need clear thought processes for diagnosis and treatment. Ethical considerations, diagnosis, identity and previous history, contraindications, time of symptom onset (EDICT) can help decision-making in this situation.
- ischemic stroke
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors SMB and MSR devised the article. All authors equally contributed to the creation and writing of the article.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by William Whiteley, Edinburgh, UK.
Read the full text or download the PDF:
Other content recommended for you
- Low relative diffusion weighted image signal intensity can predict good prognosis after endovascular thrombectomy in patients with acute ischemic stroke
- Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging
- Factors associated with prehospital delay in acute stroke
- Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
- Management of a wake-up stroke
- Validity of a computerised five-level emergency triage system for patients with acute ischaemic stroke
- Collateral flow as causative of good outcomes in endovascular stroke therapy
- Thrombolysis in patients with WAKE-UP or unknown time of stroke onset: ready for prime time?
- Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome
- The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies